[Expectations in the clinical application of human-recombinant cytokines. 3) Tumor necrosis factor and lymphotoxins].
D000818:Animals; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage; D008233:Lymphotoxin-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma